Avadel Pharmaceuticals (AVDL) Liabilities from Discontinued Operations: 2013-2014
Historic Liabilities from Discontinued Operations for Avadel Pharmaceuticals (AVDL) over the last 1 years, with Dec 2014 value amounting to $168,000.
- Avadel Pharmaceuticals' Liabilities from Discontinued Operations fell 97.82% to $168,000 in Q4 2014 from the same period last year, while for Dec 2014 it was $168,000, marking a year-over-year decrease of 97.82%. This contributed to the annual value of $168,000 for FY2014, which is 97.82% down from last year.
- As of Q4 2014, Avadel Pharmaceuticals' Liabilities from Discontinued Operations stood at $168,000, which was up 839,900.00% from $20 recorded in Q2 2014.
- Over the past 5 years, Avadel Pharmaceuticals' Liabilities from Discontinued Operations peaked at $7.7 million during Q4 2013, and registered a low of $10 during Q1 2014.
- Its 2-year average for Liabilities from Discontinued Operations is $2.0 million, with a median of $84,010 in 2014.
- Data for Avadel Pharmaceuticals' Liabilities from Discontinued Operations shows a maximum YoY tumbled of 97.82% (in 2014) over the last 5 years.
- Avadel Pharmaceuticals' Liabilities from Discontinued Operations (Quarterly) stood at $7.7 million in 2013, then slumped by 97.82% to $168,000 in 2014.
- Its last three reported values are $168,000 in Q4 2014, $20 for Q2 2014, and $10 during Q1 2014.